|
Cancer and Tumor Development: Biomedical Background |
|
|
Cell-Cycle Specific Cancer Chemotherapy for Homogeneous Tumors |
|
|
Cancer Chemotherapy for Heterogeneous Tumor Cell Populations and Drug Resistance |
|
|
Optimal Control for Problems with a Quadratic Cost Functional on the Therapeutic Agents |
|
|
Optimal Control of Mathematical Models for Antiangiogenic Treatments |
|
|
Robust Suboptimal Treatment Protocols for Antiangiogenic Therapy |
|
|
Combination Therapies with Antiangiogenic Treatments |
|
|
Optimal Control for Mathematical Models of Tumor Immune System Interactions |
|
|
Concluding Remarks |
|
|
Appendices |
|
|
Cancer and Tumor Development: Biomedical Background |
|
|
Cell-Cycle Specific Cancer Chemotherapy for Homogeneous Tumors |
|
|
Cancer Chemotherapy for Heterogeneous Tumor Cell Populations and Drug Resistance |
|
ＥＢ
